# OnCo record nct07720193 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07720193/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07720193", "NCT07720193" ;
  schema:name "A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC"@en ;
  schema:description "A phase 3 trial of Opamtistomig run by Nanjing Leads Biolabs Co.,Ltd, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07720193/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07720193> ;
  onco:status "planned" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/> ;
  onco:drugs <https://onco.cc/drugs/opamtistomig/> ;
  onco:companies <https://onco.cc/companies/nanjing-leads-biolabs/> .